DrugProtAI: A machine learning–driven approach for predicting protein druggability through feature engineering and robust partition-based ensemble methods
Briefings in Bioinformatics · 2025
DOI: 10.1093/bib/bbaf330 ↗Kurz gefasst
Fachartikel in der Zeitschrift Briefings in Bioinformatics, 2025. Verfasst von Ankit Halder und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Powai, Mumbai 400076, Maharashtra, India. Hauptthemen laut MEDLINE: Machine Learning, Proteins, Computational Biology, Software. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: MHRD-UAY Project (UCHHATAR AVISHKAR YOJANA), MASSFIITB, Department of Biotechnology.
Abstract (Originalsprache)
Drug design and development are central to clinical research, yet 90% of drugs fail to reach the clinic, often due to inappropriate selection of drug targets. Conventional methods for target identification lack precision and sensitivity. While various computational tools have been developed to predict the druggability of proteins, they often focus on limited subsets of the human proteome or rely solely on amino acid properties. Our study presents DrugProtAI, a tool developed by implementing a partitioning-based method and trained on the entire human protein set using both sequence- and non–sequence-derived properties. The partitioned method was evaluated using popular machine learning algorithms, of which Random Forest and XGBoost performed the best. A comprehensive analysis of 183 features, encompassing biophysical, sequence-, and non–sequence-derived properties, achieved a median Area Under Precision-Recall Curve (AUC) of 0.87 in target prediction. The model was further tested on a blinded validation set comprising recently approved drug targets. The key predictors were also identified, which we believe will help users in selecting appropriate drug targets. We believe that these insights are poised to significantly advance drug development. This version of the tool provides the probability of druggability for human proteins. The tool is freely accessible at https://drugprotai.pythonanywhere.com/.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Powai, Mumbai 400076, Maharashtra, India.
- Department of Computer Science and Engineering, Indian Institute of Technology Bombay, Powai, Mumbai 400076, Maharashtra, India.
- Department of Civil Engineering, Indian Institute of Technology Bombay, Powai, Mumbai 400076, Maharashtra, India.
- Department of Mechanical Engineering, Indian Institute of Technology Bombay, Powai, Mumbai 400076, Maharashtra, India.
ORCID-Profile: Sanjeeva Srivastava
Förderung
- MHRD-UAY Project (UCHHATAR AVISHKAR YOJANA)
- MASSFIITB
- Department of Biotechnology
- Ministry of Education, India
Zitieren
APA
Halder, A., Samantaray, S., Barbade, S., Gupta, A., & Srivastava, S. (2025). DrugProtAI: A machine learning–driven approach for predicting protein druggability through feature engineering and robust partition-based ensemble methods. Briefings in Bioinformatics. https://doi.org/10.1093/bib/bbaf330
Vancouver
Halder A, Samantaray S, Barbade S, Gupta A, Srivastava S. DrugProtAI: A machine learning–driven approach for predicting protein druggability through feature engineering and robust partition-based ensemble methods. Briefings in Bioinformatics. 2025. doi:10.1093/bib/bbaf330
BibTeX
@article{Halder2025,
author = {Halder, Ankit and Samantaray, Sabyasachi and Barbade, Sahil and Gupta, Aditya and Srivastava, Sanjeeva},
title = {DrugProtAI: A machine learning–driven approach for predicting protein druggability through feature engineering and robust partition-based ensemble methods},
journal = {Briefings in Bioinformatics},
year = {2025},
doi = {10.1093/bib/bbaf330}
}
EUVIMED